| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Data standards in drug discovery: A long way to go
|
Kelm, Jens M.
|
|
|
29 |
2 |
p.
|
artikel
|
| 2 |
Design strategies and recent development of bioactive modulators for glutamine transporters
|
Cheng, Xinying
|
|
|
29 |
2 |
p.
|
artikel
|
| 3 |
Drug–drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs
|
Wang, Hongge
|
|
|
29 |
2 |
p.
|
artikel
|
| 4 |
Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
|
Yang, Wenzhan
|
|
|
29 |
2 |
p.
|
artikel
|
| 5 |
GPR39: An orphan receptor begging for ligands
|
Doboszewska, Urszula
|
|
|
29 |
2 |
p.
|
artikel
|
| 6 |
Human carnosinases: A brief history, medicinal relevance, and in silico analyses
|
Chmielewska, Klaudia
|
|
|
29 |
2 |
p.
|
artikel
|
| 7 |
Increased contribution of small companies to late-entry drugs: a changing trend in FDA-approved drugs during the 2020s
|
Okuyama, Ryo
|
|
|
29 |
2 |
p.
|
artikel
|
| 8 |
Mapping the evolution of inhaled drug delivery research: Trends, collaborations, and emerging frontiers
|
Li, Xinyuan
|
|
|
29 |
2 |
p.
|
artikel
|
| 9 |
Mechanisms and prospects of piezoelectric materials as smart delivery vehicles in cancer treatment
|
Fayaz, Haleema
|
|
|
29 |
2 |
p.
|
artikel
|
| 10 |
Recent advances in dual-drug co-amorphous systems
|
Shelke, Rutuja
|
|
|
29 |
2 |
p.
|
artikel
|
| 11 |
Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy
|
Wu, Ke-Jia
|
|
|
29 |
2 |
p.
|
artikel
|
| 12 |
Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer
|
Mao-mao,
|
|
|
29 |
2 |
p.
|
artikel
|
| 13 |
The potential value of 5-androstenediol in countering acute radiation syndrome
|
Singh, Vijay K.
|
|
|
29 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving